Medicure Inc.
MPH.V
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 21.11% | 7.61% | -3.45% | -0.57% | -8.82% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 21.11% | 7.61% | -3.45% | -0.57% | -8.82% |
| Cost of Revenue | 43.18% | 24.23% | 17.78% | 16.40% | 33.35% |
| Gross Profit | 3.54% | -3.42% | -15.64% | -9.89% | -27.17% |
| SG&A Expenses | -2.14% | -2.96% | -4.54% | 0.95% | 2.91% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.57% | 7.01% | 5.07% | 8.92% | 14.80% |
| Operating Income | 25.12% | -2.61% | -136.84% | -254.36% | -447.45% |
| Income Before Tax | -59.04% | 57.09% | -33.02% | 13.91% | -270.22% |
| Income Tax Expenses | 187.07% | 120.85% | 413.32% | 875.79% | 98.29% |
| Earnings from Continuing Operations | -65.03% | 50.79% | -49.50% | -11.23% | -286.40% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -65.03% | 50.79% | -49.50% | -11.23% | -286.40% |
| EBIT | 25.12% | -2.61% | -136.84% | -254.36% | -447.45% |
| EBITDA | 45.42% | 0.44% | -594.99% | -227.22% | -178.45% |
| EPS Basic | -65.06% | 50.81% | -49.39% | -11.68% | -284.50% |
| Normalized Basic EPS | 24.73% | -4.12% | -138.46% | -227.44% | -469.28% |
| EPS Diluted | -66.28% | 48.32% | -49.82% | -10.25% | -302.09% |
| Normalized Diluted EPS | 24.73% | -3.87% | -136.91% | -223.29% | -475.47% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.34% | 0.78% |
| Average Diluted Shares Outstanding | -0.14% | -3.12% | -3.26% | -2.98% | -2.98% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |